| Literature DB >> 24913619 |
Yu Zhou, Yi Wang, XiuYing Wang, Gerald Volière, RongDang Hu1.
Abstract
BACKGROUND: Although a great number of specific quality of life measures have been developed to analyze the impact of wearing fixed appliances, there is still a paucity of systematic appraisal of the consequences of orthodontics on quality of life. To assess the current evidence of the relationship between orthodontic treatment and quality of life.Entities:
Mesh:
Year: 2014 PMID: 24913619 PMCID: PMC4060859 DOI: 10.1186/1472-6831-14-66
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 2.757
Oxford Centre for Evidence-based Medicine Levels of Evidence
| 1a | SR (with homogeneity) of RCTs | SR (with homogeneity) of inception cohort studies; validated in different populations | SR (with homogeneity) of Level 1 diagnostic studies; with 1b studies from different clinical centres | SR (with homogeneity) of prospective cohort studies | SR (with homogeneity) of Level 1 economic studies |
| 1b | Individual RCT (with narrow Confidence Interval) | Individual inception cohort study with > 80% follow-up; validated in a single population | Validating cohort study with good reference standards; or tested within one clinical centre | Prospective cohort study with good follow-up | Analysis based on clinically sensible costs or alternatives; systematic review(s) of the evidence; and including multi-way sensitivity analyses |
| 1c | All or none | All or none case-series | | All or none case-series | Absolute better-value or worse-value analyses |
| 2a | SR (with homogeneity) of cohort studies | SR (with homogeneity) of either retrospective cohort studies or untreated control groups in RCTs | SR (with homogeneity) of Level >2 diagnostic studies | SR (with homogeneity) of 2b and better studies | SR (with homogeneity) of Level >2 economic studies |
| 2b | Individual cohort study (including low quality RCT; e.g., <80% follow-up) | Retrospective cohort study or follow-up of untreated control patients in an RCT; Derivation of CDR or validated on split-samples only | Exploratory cohort study with good reference standards; after derivation, or validated only on split-samples or databases | Retrospective cohort study, or poor follow-up | Analysis based on clinically sensible costs or alternatives; limited review(s) of the evidence, or single studies; and including multi-way sensitivity analyses |
| 2c | “Outcomes” Research; Ecological studies | “Outcomes” Research | | Ecological studies | Audit or outcomes research |
| 3a | SR (with homogeneity) of case-control studies | | SR (with homogeneity) of 3b and better studies | SR (with homogeneity) of 3b and better studies | SR (with homogeneity) of 3b and better studies |
| 3b | Individual Case-Control Study | | Non-consecutive study; or without consistently applied reference standards | Non-consecutive cohort study, or very limited population | Analysis based on limited alternatives or costs, poor quality estimates of data, but including sensitivity analyses incorporating clinically sensible variations. |
| 4 | Case-series (and poor quality cohort and case-control studies) | Case-series (and poor quality prognostic cohort studies) | Case-control study, poor or non-independent reference standard | Case-series or superseded reference standards | Analysis with no sensitivity analysis |
| 5 | Expert opinion without explicit critical appraisal, or based on physiology, bench research or “first principles” | Expert opinion without explicit critical appraisal, or based on physiology, bench research or “first principles” | Expert opinion without explicit critical appraisal, or based on physiology, bench research or “first principles” | Expert opinion without explicit critical appraisal, or based on physiology, bench research or “first principles” | Expert opinion without explicit critical appraisal, or based on economic theory or “first principles” |
Produced by Bob Phillips, Chris Ball, Dave Sackett, Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. Updated by Jeremy Howick March 2009.
Figure 1Flowchart for study inclusion and exclusion (n, number of studies).
Summary of Studies: Study Design, Sample and Quality-of-Life (QoL) Instruments
| Eduardo, [ | Case-control | Nonrandomized | 837 | 15-16 y | Previous 6 month | CS-OIDP | 0.16-0.46 | p < 0.001 | 2C |
| Daniela, [ | Longtitude | NOT mentioned | 284 | 12-15 y | 2 years | OHIP-14 | — | p < 0.01 | 1B |
| Shoroog, 2011 | Longtitude | Consecutive | 118 | 11-14 y | More than 2 years | CPQ11-14 | — | p < 0.01 | 1B |
| Zhijian, [ | Longtitude | Consecutive | 232 | 16 and older | 18 month | OHIP-14 and OHQoL-UK | — | p < 0.01 (6 m), P < 0.01 (12 m), p < 0.05 (18 m) | 1B |
| Man, [ | Longtitude | Consecutive | 198 | 13.1 ± 1.5 | 6 month | CPQ | — | p < 0.001 (first week), P < 0.05 (1 month) | 1B |
| Mu, 2009 | Longtitude | NOT mentioned | 250 | Mean 15, 7 y | More than 2 years | OHIP-14 | — | p < 0.001 | 1B |
| Yueming, 2012 | Longtitude | Consecutive | 300 | 18-36 y | From begin to 6 months after posttreatment | OHIP-14 | — | p < 0.01 | 1B |
| Andrea, 2011 | Cross-sectional | Nonrandomized | 579 | 11-14 y | - | CPQ11-14 | 1.11-2.33 | p = 0.007 | 3B |
| Aihua, [ | Cross-sectional | Nonrandomized | 182 | 7-33 y | 1-month post-insertion | OHIP-14 | — | p < 0.01 | 3B |
| Nathalia, 2012 | Cross-sectional | Consecutive | 200 | 18-30 y | After treatment more than 6 month | OHIP-14 | — | p < 0.01 | 3B |
| Oliveira, 2003 | Cross-sectional | Nonrandomized | 1675 | 15-16 y | - | OIDP and OHIP | 1.30-2.62 | p < 0.001 | 2C |